We recently updated our soy research page with a 2019 dose-response meta-analysis of 23 prospective studies. It included a total of 330,826 participants and found that both soy protein and soy isoflavones had a positive impact on breast cancer mortality (1). A 10 mg/day increase in soy isoflavone intake was associated with a 9% decreased risk of breast cancer mortality, and a 5 g/day increase in soy protein intake was associated with a 12% reduction in breast cancer death (1).
You may also like
by Jack Norris, RD, LD We’ve added two appendices to our article, Omega-3s Part 2: Research: Appendix A: Biomarkers of DHA Status […]
By Jack Norris, RD, LD I’ve concluded a personal experiment using a daily multivitamin that I conducted after writing the article, Are […]
by Jack Norris, Registered Dietitian Does drinking cow’s milk raise estrogen levels in humans? You might think this question would have been […]
The NIH and AAP consider soy formula safe for term infants.